Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactionsglobenewswire.com
ACV Expands MAX Suite, Delivers AI-Powered, Profit-Focused Inventory Guidance with New ACV MAX Recommendations Featurebusinesswire.com